Disproportionate regulation hampers research into potentially lifesaving treatments without enhancing patient safety, say eight UK non-commercial research organisations.
They have joined the European Science Foundation and other European cancer and clinical charities to call for changes in the European Clinical Trials Directive.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.